PO029 | IMPACT OF HEPATOCELLULAR CARCINOMA ON CIRCULATING RETICULATED PLATELETS IN PATIENTS WITH AND WITHOUT LIVER CIRRHOSIS
Abstract
Background and Aims. Reticulated platelets (RePLTs) are bigger and more reactive platelets with an increased RNA content. In liver cirrhosis, increased platelet turnover leads to the release of these “emergency platelets'', which would counteract bleeding events. However, their role in hepatocellular carcinoma (HCC) remains unclear. The aim of this study is to evaluate RePLT levels and platelet activation in HCC patients with and without cirrhosis. Methods. Sixty subjects were prospectively enrolled into four groups: healthy controls (CTRL), cirrhosis without HCC (cirrhosis+ HCC-), HCC on a healthy liver (cirrhosis- HCC+), and HCC on cirrhosis (cirrhosis+ HCC+). Exclusion criteria were advanced liver disease (Child-Pugh B/C), portal vein thrombosis and antiplatelet therapy. RePLTs were defined through CD41 and SYTO-13 positivity in the morphological gate set between the 3 µm and 10 μm beads population diameter using flow cytometry and their activation was evaluated by phosphatidylserine and P-selectin exposure across different reticulation strata (low/high/very-high). Multivariable linear regression assessed the independent association between HCC and RePLTs. Repeated-measures ANOVA tested the effect of reticulation and group interaction. Results. Sixty subjects were included: CTRL (n = 28), cirrhosis+ HCC- (n = 16), cirrhosis- HCC+ (n = 5), and cirrhosis+ HCC+ (n = 11). RePLTs were lower in HCC (median: 4.02% in CTRL, 3.76% in cirrhosis+ HCC-, 1.98% in cirrhosis- HCC+, and 1.55% in cirrhosis+ HCC+; p = 0.004). In a multivariable linear regression, HCC was independently associated with reduced RePLTs (coefficient -2.51%; 95% CI -4.55 to -0.46; p = 0.018). Both phosphatidylserine and P-selectin increased significantly with increasing reticulation (p < 0.001 for both). The increase across reticulation strata differed by group for both markers (p < 0.001 for both), showing blunted activation in HCC groups. Specifically, in the three reticulation strata, phosphatidylserine increased from 1.07%, 8.29% and 46.0% in CTRL and 0.57%, 11.5% and 68.6% in cirrhosis+ HCC–, with smaller increases in cirrhosis– HCC+ (2.54%, 2.83% and 7.27%) and cirrhosis+ HCC+ (4.74%, 7.54% and 20%). Similarly, P-selectin increased from 3.02%, 29.6% to 93.7% in CTRL and 3.63%, 45.6% to 96.6% in cirrhosis+ HCC–, versus more limited increases in cirrhosis– HCC+ (1.29%, 2.38% to 15.6%) and cirrhosis+ HCC+ (1.59%, 5.01% to 35.3%). Conclusions. HCC is independently associated with decreased levels of circulating RePLTs. HCC patients exhibited reduced platelet activation as reticulation increases, as demonstrated by significant reticulation-by-group interactions for both phosphatidylserine and P-selectin. Further studies are needed to elucidate the underlying mechanisms and clinical relevance.
Related
- The CYB5R3–mARC1 Redox Axis in Metabolic Dysfunction-associated Steatotic Liver Disease: Mechanistic Basis and Therapeutic Prospects across the Steatosis–Cirrhosis–Hepatocellular Carcinoma Spectrum
- Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
- A tumor–immune balance index from stem-like circulating tumor cells is associated with outcomes after yttrium-90 radioembolization for hepatocellular carcinoma
- Sleep disorders as an emerging risk factor for liver cirrhosis and hepatocellular carcinoma: a systematic review and meta-analysis of cohort studies.
- Interaction between microvascular invasion and early recurrence of hepatocellular carcinoma in cirrhosis patients with curative liver resection: a retrospective cohort study.
BibTeX
@article{toffanin2026po029,
title = {{PO029 | IMPACT OF HEPATOCELLULAR CARCINOMA ON CIRCULATING RETICULATED PLATELETS IN PATIENTS WITH AND WITHOUT LIVER CIRRHOSIS}},
author = {Serena Toffanin},
journal = {Bleeding, Thrombosis and Vascular Biology},
year = {2026},
month = oct,
url = {https://www.btvb.org/btvb/article/view/845},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - PO029 | IMPACT OF HEPATOCELLULAR CARCINOMA ON CIRCULATING RETICULATED PLATELETS IN PATIENTS WITH AND WITHOUT LIVER CIRRHOSIS
AU - Serena Toffanin
PY - 2026
DA - 2026/10/26
JO - Bleeding, Thrombosis and Vascular Biology
UR - https://www.btvb.org/btvb/article/view/845
AB - Background and Aims. Reticulated platelets (RePLTs) are bigger and more reactive platelets with an increased RNA content. In liver cirrhosis, increased platelet turnover leads to the release of these “emergency platelets'', which would counteract bleeding events. However, their role in hepatocellular carcinoma (HCC) remains unclear. The aim of this study is to evaluate RePLT levels and platelet activation in HCC patients with and without cirrhosis. Methods. Sixty subjects were prospectively enrolled into four groups: healthy controls (CTRL), cirrhosis without HCC (cirrhosis+ HCC-), HCC on a healthy liver (cirrhosis- HCC+), and HCC on cirrhosis (cirrhosis+ HCC+). Exclusion criteria were advanced liver disease (Child-Pugh B/C), portal vein thrombosis and antiplatelet therapy. RePLTs were defined through CD41 and SYTO-13 positivity in the morphological gate set between the 3 µm and 10 μm beads population diameter using flow cytometry and their activation was evaluated by phosphatidylserine and P-selectin exposure across different reticulation strata (low/high/very-high). Multivariable linear regression assessed the independent association between HCC and RePLTs. Repeated-measures ANOVA tested the effect of reticulation and group interaction. Results. Sixty subjects were included: CTRL (n = 28), cirrhosis+ HCC- (n = 16), cirrhosis- HCC+ (n = 5), and cirrhosis+ HCC+ (n = 11). RePLTs were lower in HCC (median: 4.02% in CTRL, 3.76% in cirrhosis+ HCC-, 1.98% in cirrhosis- HCC+, and 1.55% in cirrhosis+ HCC+; p = 0.004). In a multivariable linear regression, HCC was independently associated with reduced RePLTs (coefficient -2.51%; 95% CI -4.55 to -0.46; p = 0.018). Both phosphatidylserine and P-selectin increased significantly with increasing reticulation (p < 0.001 for both). The increase across reticulation strata differed by group for both markers (p < 0.001 for both), showing blunted activation in HCC groups. Specifically, in the three reticulation strata, phosphatidylserine increased from 1.07%, 8.29% and 46.0% in CTRL and 0.57%, 11.5% and 68.6% in cirrhosis+ HCC–, with smaller increases in cirrhosis– HCC+ (2.54%, 2.83% and 7.27%) and cirrhosis+ HCC+ (4.74%, 7.54% and 20%). Similarly, P-selectin increased from 3.02%, 29.6% to 93.7% in CTRL and 3.63%, 45.6% to 96.6% in cirrhosis+ HCC–, versus more limited increases in cirrhosis– HCC+ (1.29%, 2.38% to 15.6%) and cirrhosis+ HCC+ (1.59%, 5.01% to 35.3%). Conclusions. HCC is independently associated with decreased levels of circulating RePLTs. HCC patients exhibited reduced platelet activation as reticulation increases, as demonstrated by significant reticulation-by-group interactions for both phosphatidylserine and P-selectin. Further studies are needed to elucidate the underlying mechanisms and clinical relevance.
SN - 2785-5309
ER -